Tag: Quentis Therapeutics

Innovation, Research

New York Firm Raises $48 Million To Develop New Cancer Immunotherapies

February 27, 2018

Via: Forbes

The firm, Quentis Therapeutics, says that the money will fund clinical trials for its new medicine, a small molecule IRE1α inhibitor, to begin next year. The idea is that harsh conditions within tumors inhibit the immune system from attacking the […]